In addition, the constructs were not only delivered to the extracellular vesicles fraction, but also correctly processed by cathepsin B protease as demonstrated by the differential ratio between the fusion products carrying the CS or NACS sequences in cancer cells. The gene discussed is CS; the disease is cancer.